cycloheximide has been researched along with Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, JA; Doyle, K; King, S; Lessov, NS; Meller, R; Minami, M; Rosenzweig, H; Simon, RP; Stenzel-Poore, MP; Stevens, SL | 1 |
| Choi, D | 1 |
| Camandola, S; Mattson, MP; Poli, G | 1 |
3 other study(ies) available for cycloheximide and Stroke
| Article | Year |
|---|---|
Neuroprotection by osteopontin in stroke.
Topics: Animals; Blotting, Western; Brain; Brain Ischemia; Cells, Cultured; Cycloheximide; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Neuroprotective Agents; Oligopeptides; Osteopontin; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Sialoglycoproteins; Stroke | 2005 |
Stroke.
Topics: Animals; Apoptosis; Cycloheximide; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Intracranial Embolism; Necrosis; Neuroprotective Agents; Plasminogen Activators; Spinal Cord Injuries; Stroke; Tissue Plasminogen Activator | 2000 |
The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons.
Topics: Aldehydes; Alzheimer Disease; Animals; Apoptosis; Cell Survival; Cells, Cultured; Cerebral Cortex; Cycloheximide; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Lipid Peroxidation; Nerve Degeneration; Neurons; NF-kappa B; Okadaic Acid; Protein Synthesis Inhibitors; Rats; Stroke; Transcription Factor AP-1; Vanadates | 2000 |